The European Journal of Public Health Advance Access originally published online on January 6, 2009
The European Journal of Public Health 2009 19(1):5-6; doi:10.1093/eurpub/ckn120
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
© The Author 2009. Published by Oxford University Press on behalf of the European Public Health Association. All rights reserved.
Commentary |
Testing at home—the screening of the future?*
Harry J. de KoningCorrespondence: Harry J. de Koning, MD, PhD, Professor of Screening Evaluation, Erasmus MC, Department of Public Health, PO Box 2040, 3000 CA Rotterdam, The Netherlands, tel: 31 107038460, fax: 31 107038475, e-mail: h.dekoning@erasmusmc.nl
| The first 10% of the full text of this article appears below. |
Cardiovascular diseases (CVD) and diabetes mellitus (DM) are major public health concerns in modern society. Although mortality from CVD has decreased substantially in many European countries in the past 30 years due to better prevention (e.g. encouraging people to stop smoking and discouraging people from starting) and better medicinal treatment, CVD remains the category of diseases with the highest number of life-years lost. Due to sedentary lifestyles and unfavourable nutrition habits, obesity has developed into a new epidemic with adverse consequences for CVD and DM. Type 2 diabetes is